The Excellence in Research for Australia 2010 report shows that Australian researchers produce world class output in immunology, quantum physics and history, but fall behind in other areas.
Eight out of the 34 universities surveyed in the Excellence in Research Australia report produce life science research that is well above the world standard.
The Australian Academy of Science will hold a public lecture series that will serve as a tribute to the life and achievements of the late Frank Fenner.
Biotechnology industry veteran, Mike Hirshorn, appointed as non-executive director of clinical and diagnostic technology company LBT Innovations (ASX:LBT).
The University of Queensland campus at St Lucia has been hit by the once in a century flood.
Australian xenotransplantation pioneers Living Cell Technologies announced today that the New Zealand minister of health has approved the expansion of the company’s clinical trial of Diabecell, a porcine-based implant designed to treat Type 1 diabetes.
S&P/ASX 200 Heathcare Index closed just 22 points shy of 9000 today after notching up its sixth consecutive week in the black.
Mayne Pharma Group has applied for a marketing authorisation application (MAA) with the European Union (EU) for the sale and supply of its Subacap drug to treat fungal infections.
Thermo Fisher continues its acquisition frenzy by agreeing to buy laboratory equipment manufacturer, Dionex, for US$2.1 billion ($2.11 billion).
Super resolution microscopy has broken the light (refraction) barrier to allow the study of cells and their components in unprecedented detail.
Four life science researchers are among 23 Australian scientists, young and old, who have received Australian Academy of Science awards for scientific excellence.
Using some innovative techniques in electron microscopy, Rob Parton and his team are gaining an insight into a little understood feature of cells.
Queensland is set to have a new industry body representing the full breadth of the life sciences and biotechnology industries with the establishment of Life Sciences Queensland (LSQ), which will launch in 2011.
AusBiotech and Medicines Australia (MA) are urging all biotech and life sciences companies likely to be affected by proposed amendments to patenting legislation, as it relates to genes and other biological materials, to hurry up and make their submissions to the second senate Inquiry before the deadline of February 25, 2011.
Thermo Fisher continues to expand into the Australia-New Zealand market through the signing of a definitive agreement to acquire Lomb Scientific.